TY - JOUR
KW - Anxiety
KW - Depression
KW - Insomnia
KW - opioid dependence
KW - Extended-release naltrexone
KW - buprenorphine
KW - Randomized Clinical Trial
KW - Clinical Trial
KW - Empirical Study
KW - Followup Study
KW - Longitudinal Study
KW - Prospective Study
KW - Quantitative Study
KW - Human
KW - Male
KW - Female
KW - Adulthood (18 yrs & older)
KW - opioid use disorder
KW - Drug Therapy
KW - Depression (Emotion)
KW - Side Effects (Drug)
KW - Naltrexone
KW - Randomized Clinical Trials
KW - article
KW - US
KW - 3383:Drug & Alcohol Rehabilitation
AU - Zill-e-Huma Latif
AU - Jūratė Šaltytė Benth
AU - Kristin Klemmetsby Solli
AU - Arild Opheim
AU - Nikolaj Kunoe
AU - Peter Krajci
AU - Kamni Sharma-Haase
AU - Lars Tanum
A1 - 
AD - Department of Research and Development in Mental Health, Akershus University Hospital, Lorenskog, Norway zill-e-huma.latif@ahus.no; Institute of Clinical Medicine, University of Oslo, Oslo, Norway ; Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway ; Department of Addiction Medicine, Oslo University Hospital, Oslo, Norway ; Norwegian Center for Addiction Research, University of Oslo, Oslo, Norway ; Latif, Zill-e-Huma,Road Sykehusveien 25, PO Box 1000,Lorenskog,Norway,1478,Department of Research and Development in Mental Health, Akershus University Hospital,zill-e-huma.latif@ahus.no
BT - JAMA Psychiatry
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CP - 2
DO - 10.1001/jamapsychiatry.2018.3537
IS - 2
JF - JAMA Psychiatry
LA - English
M1 - Journal Article
PB - American Medical Association
PY - 2019
SN - 2168-622X, 2168-622X
SP - 127
EP - 134
EP - 
T1 - Anxiety, depression, and insomnia among adults with opioid dependence treated with extended-release naltrexone vs buprenorphine-naloxone: A randomized clinical trial and follow-up study
T2 - JAMA Psychiatry
TI - Anxiety, depression, and insomnia among adults with opioid dependence treated with extended-release naltrexone vs buprenorphine-naloxone: A randomized clinical trial and follow-up study
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U3 - 10.1001/jamapsychiatry.2018.3537
VL - 76
VO - 2168-622X, 2168-622X
Y1 - 2019
Y2 - 02
ER -